Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Pyridoxine and dietary counseling for the management of idiopathic hyperoxaluria in stone-forming patients.

Ortiz-Alvarado O, Miyaoka R, Kriedberg C, Moeding A, Stessman M, Monga M.

Urology. 2011 May;77(5):1054-8. doi: 10.1016/j.urology.2010.08.002. Epub 2011 Feb 19.

PMID:
21334732
2.

Control of hyperoxaluria with large doses of pyridoxine in patients with kidney stones.

Mitwalli A, Ayiomamitis A, Grass L, Oreopoulos DG.

Int Urol Nephrol. 1988;20(4):353-9.

PMID:
3170105
4.

[Pyridoxine can normalize oxaluria in idiopathic renal lithiasis].

Jaeger P, Portmann L, Jacquet AF, Burckhardt P.

Schweiz Med Wochenschr. 1986 Dec 13;116(50):1783-6. French.

PMID:
3798070
5.

Effect of magnesium and pyridoxine supplementation on glycolate induced hyperoxaluria in male albino rats.

Gulati S, Narula R, Sadhna S, Sidhu H, Wangoo D, Thind SK, Nath R.

Indian J Exp Biol. 1988 Jul;26(7):525-7. No abstract available.

PMID:
3198153
6.

Mild metabolic hyperoxaluria and its response to pyridoxine.

Gill HS, Rose GA.

Urol Int. 1986;41(5):393-6.

PMID:
3811039
7.

Effect of dietary changes on urinary oxalate excretion and calcium oxalate supersaturation in patients with hyperoxaluric stone formation.

Penniston KL, Nakada SY.

Urology. 2009 Mar;73(3):484-9. doi: 10.1016/j.urology.2008.10.035. Epub 2009 Jan 1.

PMID:
19118878
8.

Effect of high-calcium diet on urinary oxalate excretion in urinary stone formers.

Nakada T, Sasagawa I, Furuta H, Katayama T, Shimazaki J.

Eur Urol. 1988;15(3-4):264-70.

PMID:
3215261
9.

Effect of pyridoxine supplementation on recurrent stone formers.

Murthy MS, Farooqui S, Talwar HS, Thind SK, Nath R, Rajendran L, Bapna BC.

Int J Clin Pharmacol Ther Toxicol. 1982 Sep;20(9):434-7.

PMID:
7141762
10.

Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria.

Milliner DS, Eickholt JT, Bergstralh EJ, Wilson DM, Smith LH.

N Engl J Med. 1994 Dec 8;331(23):1553-8.

11.

Hyperoxaluria in patients with recurrent calcium oxalate calculi: dietary and other risk factors.

Laminski NA, Meyers AM, Kruger M, Sonnekus MI, Margolius LP.

Br J Urol. 1991 Nov;68(5):454-8.

PMID:
1747716
12.

Effect of verapamil on urinary stone-forming risk factors.

Sarica K, Erturhan S, Altay B.

Urol Res. 2007 Feb;35(1):23-7. Epub 2006 Dec 13.

PMID:
17165082
13.
14.

[Oxalates and the digestive tract].

Gendre JP.

Ann Gastroenterol Hepatol (Paris). 1990 Mar-Apr;26(2):81-4. Review. French. No abstract available.

PMID:
2189358
15.

[Idiopathic calcium lithiasis. Dietary correction of metabolic risk factors. Physiopathological bases].

Bataille P, Pruna A, Hottelart C, Ghazali A, Oprisiu R, Rumpala C, Hardy P, Achard JM, Fournier A.

Presse Med. 1998 Feb 7;27(5):218-24. Review. French. No abstract available.

PMID:
9768017
16.

Hyperoxaluria type I: therapeutic effects of pyridoxine hydrochloride and inheritance patterns of the disease in a family.

Yano S, Yoshino M, Nishiyori A, Nakao M, Matsumoto T, Ito Y, Yamashita F, Shimada A, Inokuchi T.

Kurume Med J. 1988;35(3):127-33. No abstract available.

17.

Vitamin B6 metabolites in idiopathic calcium stone formers: no evidence for a link to hyperoxaluria.

Kaelin A, Casez JP, Jaeger P.

Urol Res. 2004 Feb;32(1):61-8. Epub 2003 Nov 20.

PMID:
14628106
18.

Hyperoxaluria and recurrent stone formation apparently cured by short courses of pyridoxine.

Harrison AR, Kasidas GP, Rose GA.

Br Med J (Clin Res Ed). 1981 Jun 27;282(6282):2097-8. No abstract available.

19.
20.

The urinary response to an oral oxalate load in recurrent calcium stone formers.

Krishnamurthy MS, Hruska KA, Chandhoke PS.

J Urol. 2003 Jun;169(6):2030-3.

PMID:
12771711
Items per page

Supplemental Content

Write to the Help Desk